Sanofi Consumer Healthcare India Ltd
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Dec 2023 | Dec 2024 | |
|---|---|---|
| Allegra Market Share (Allergy Category) % ・Standalone data |
|
|
| Avil Market Share (Allergy Category) % ・Standalone data |
||
| City Reach Number of Cities ・Standalone data |
||
| Combiflam Annual Sales Volume Million Tablets ・Standalone data |
||
| Combiflam Market Share (Pain Category) % ・Standalone data |
||
| Combiflam Sales Velocity Strips per minute ・Standalone data |
||
| DePURA Market Share (Vitamin D Category) % ・Standalone data |
||
| Total Employees Number ・Standalone data |
||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Jun - Newspaper Advertisement of 3rd Annual General Meeting is enclosed.
- Reg. 34 (1) Annual Report. 4 Jun
- Shareholder Meeting - AGM On 26Th June 2026 4 Jun
-
Shareholder Meeting - AGM On 26Th June 2026
4 Jun - Sanofi Consumer Healthcare India filed its FY2025 Business Responsibility and Sustainability Report on 4 June 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Jun - Copies of newspaper advertisements regarding convening of 3rd Annual General Meeting of the Company scheduled to be held on 26th June 2026, through VC/OAVM facility.
Annual reports
Concalls
-
Mar 2026Transcript PPT
Business Overview:[1][2]
SCHIL was formed following its demerger from Sanofi India Limited, to establish a standalone Consumer Healthcare (CHC) business. It operates in the Consumer Healthcare (CHC) sector, providing self-care solutions across various health categories including allergy relief, pain management, and wellness